Picture of Benchmark Holdings logo

BMK — Benchmark Holdings Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-10.03%
3m-22.05%
6m-31.44%
1yr-33.02%
Volume Change (%)
10d/3m-86.26%
Price vs... (%)
52w High-34.75%
50d MA-11.48%
200d MA-23.45%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)62.03
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.07
Price to Tang. Book5.05
Price to Free Cashflown/a
Price to Sales2.23
EV to EBITDA14.52

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.83%
Return on Equity-6.18%
Operating Margin-2.63%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for BMK

Do analysts think that Benchmark Holdings is a buy, hold or sell? background image

Do analysts think that Benchmark Holdings is a buy, hold or sell?

Buy, hold and sell recommendations from company analysts can be a useful signal about the sentiment around a stock. Examining the 'consensus' rating among brokers can give you a sense of whether the share is worth buying or not. Take B...

What brokers are saying about Benchmark Holdings background image

What brokers are saying about Benchmark Holdings

When it comes to looking for stock market investment ideas, broker recommendations can be a useful place to start. These city experts tend to know the companies they cover inside-out, so their views can be valuable. They're even more v...

Benchmark Holdings share price hits a new 52 week high background image

Benchmark Holdings share price hits a new 52 week high

Shares in Benchmark Holdings (LON:BMK) are currently trading close to a 52 week high, with the share price up by around 3.70% to 55.5 over the past week. On a one-month basis, the Benchmark Holdings price has risen by 19.1%. For invest...

Benchmark Holdings share price hits a one-year high background image

Benchmark Holdings share price hits a one-year high

Shares in Benchmark Holdings (LON:BMK) are currently trading close to a 52 week high, with the share price up by around 12.5% to 54.645 over the past week. On a one-month basis, the Benchmark Holdings price has risen by 25.6%. For inve...

Price Alert: Benchmark Holdings outperforms over three months background image

Price Alert: Benchmark Holdings outperforms over three months

Shares in Benchmark Holdings (LON:BMK) have performed strongly against the market in recent weeks. On a 3-month relative price strength basis, the price is up by 35.9%. Its last close price was 48.5p. This kind of outperformance can be...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202230th Sep 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Benchmark Holdings EPS forecast chart

Profile Summary

Benchmark Holdings plc is an aquaculture biotechnology company. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with state-of-the-art production facilities to provide a range of genetic merit ova. Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics and sea lice treatments.

Directors

Last Annual
September 30th, 2021
Last Interim
December 31st, 2021
Incorporated
November 28th, 2000
Public Since
December 18th, 2013
No. of Employees
796
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
703,960,798

BMK Share Price Performance

Similar to BMK

Picture of Abcam logo

Abcam

gb flag iconLondon Stock Exchange

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email